These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 34113354)
1. Improvement of Neoantigen Identification Through Convolution Neural Network. Hao Q; Wei P; Shu Y; Zhang YG; Xu H; Zhao JN Front Immunol; 2021; 12():682103. PubMed ID: 34113354 [TBL] [Abstract][Full Text] [Related]
2. DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity. Wu J; Wang W; Zhang J; Zhou B; Zhao W; Su Z; Gu X; Wu J; Zhou Z; Chen S Front Immunol; 2019; 10():2559. PubMed ID: 31736974 [TBL] [Abstract][Full Text] [Related]
3. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction. Abelin JG; Harjanto D; Malloy M; Suri P; Colson T; Goulding SP; Creech AL; Serrano LR; Nasir G; Nasrullah Y; McGann CD; Velez D; Ting YS; Poran A; Rothenberg DA; Chhangawala S; Rubinsteyn A; Hammerbacher J; Gaynor RB; Fritsch EF; Greshock J; Oslund RC; Barthelme D; Addona TA; Arieta CM; Rooney MS Immunity; 2019 Oct; 51(4):766-779.e17. PubMed ID: 31495665 [TBL] [Abstract][Full Text] [Related]
4. Best practices for bioinformatic characterization of neoantigens for clinical utility. Richters MM; Xia H; Campbell KM; Gillanders WE; Griffith OL; Griffith M Genome Med; 2019 Aug; 11(1):56. PubMed ID: 31462330 [TBL] [Abstract][Full Text] [Related]
5. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations. Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG Front Immunol; 2018; 9():99. PubMed ID: 29441070 [TBL] [Abstract][Full Text] [Related]
6. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds. Prabdial-Sing N; Puren AJ; Bowyer SM BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878 [TBL] [Abstract][Full Text] [Related]
7. Population-level distribution and putative immunogenicity of cancer neoepitopes. Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567 [TBL] [Abstract][Full Text] [Related]
8. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets. Shao XM; Bhattacharya R; Huang J; Sivakumar IKA; Tokheim C; Zheng L; Hirsch D; Kaminow B; Omdahl A; Bonsack M; Riemer AB; Velculescu VE; Anagnostou V; Pagel KA; Karchin R Cancer Immunol Res; 2020 Mar; 8(3):396-408. PubMed ID: 31871119 [TBL] [Abstract][Full Text] [Related]
9. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model. Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700 [TBL] [Abstract][Full Text] [Related]
10. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy. Mitić NS; Pavlović MD; Jandrlić DR J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036 [TBL] [Abstract][Full Text] [Related]
11. The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction. Creech AL; Ting YS; Goulding SP; Sauld JFK; Barthelme D; Rooney MS; Addona TA; Abelin JG Proteomics; 2018 Jun; 18(12):e1700259. PubMed ID: 29314742 [TBL] [Abstract][Full Text] [Related]
12. RBM-MHC: A Semi-Supervised Machine-Learning Method for Sample-Specific Prediction of Antigen Presentation by HLA-I Alleles. Bravi B; Tubiana J; Cocco S; Monasson R; Mora T; Walczak AM Cell Syst; 2021 Feb; 12(2):195-202.e9. PubMed ID: 33338400 [TBL] [Abstract][Full Text] [Related]
13. Predicting HLA class II antigen presentation through integrated deep learning. Chen B; Khodadoust MS; Olsson N; Wagar LE; Fast E; Liu CL; Muftuoglu Y; Sworder BJ; Diehn M; Levy R; Davis MM; Elias JE; Altman RB; Alizadeh AA Nat Biotechnol; 2019 Nov; 37(11):1332-1343. PubMed ID: 31611695 [TBL] [Abstract][Full Text] [Related]
14. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry. Freudenmann LK; Marcu A; Stevanović S Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117 [TBL] [Abstract][Full Text] [Related]
15. Neoantigen Fitness Model Predicts Lower Immune Recognition of Cutaneous Squamous Cell Carcinomas Than Actinic Keratoses. Borden ES; Kang P; Natri HM; Phung TN; Wilson MA; Buetow KH; Hastings KT Front Immunol; 2019; 10():2799. PubMed ID: 31849976 [TBL] [Abstract][Full Text] [Related]
16. An Mishto M; Mansurkhodzhaev A; Ying G; Bitra A; Cordfunke RA; Henze S; Paul D; Sidney J; Urlaub H; Neefjes J; Sette A; Zajonc DM; Liepe J Front Immunol; 2019; 10():2572. PubMed ID: 31803176 [TBL] [Abstract][Full Text] [Related]
17. Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types. Gurung HR; Heidersbach AJ; Darwish M; Chan PPF; Li J; Beresini M; Zill OA; Wallace A; Tong AJ; Hascall D; Torres E; Chang A; Lou K'; Abdolazimi Y; Hammer C; Xavier-Magalhães A; Marcu A; Vaidya S; Le DD; Akhmetzyanova I; Oh SA; Moore AJ; Uche UN; Laur MB; Notturno RJ; Ebert PJR; Blanchette C; Haley B; Rose CM Nat Biotechnol; 2024 Jul; 42(7):1107-1117. PubMed ID: 37857725 [TBL] [Abstract][Full Text] [Related]
18. DeepNetBim: deep learning model for predicting HLA-epitope interactions based on network analysis by harnessing binding and immunogenicity information. Yang X; Zhao L; Wei F; Li J BMC Bioinformatics; 2021 May; 22(1):231. PubMed ID: 33952199 [TBL] [Abstract][Full Text] [Related]
19. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. Newey A; Griffiths B; Michaux J; Pak HS; Stevenson BJ; Woolston A; Semiannikova M; Spain G; Barber LJ; Matthews N; Rao S; Watkins D; Chau I; Coukos G; Racle J; Gfeller D; Starling N; Cunningham D; Bassani-Sternberg M; Gerlinger M J Immunother Cancer; 2019 Nov; 7(1):309. PubMed ID: 31735170 [TBL] [Abstract][Full Text] [Related]
20. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens. Nosrati M; Mohabatkar H; Behbahani M Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]